1. Home
  2. ALT vs ADV Comparison

ALT vs ADV Comparison

Compare ALT & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • ADV
  • Stock Information
  • Founded
  • ALT 1997
  • ADV 1987
  • Country
  • ALT United States
  • ADV United States
  • Employees
  • ALT N/A
  • ADV N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • ADV Business Services
  • Sector
  • ALT Health Care
  • ADV Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • ADV Nasdaq
  • Market Cap
  • ALT 397.4M
  • ADV 428.1M
  • IPO Year
  • ALT N/A
  • ADV N/A
  • Fundamental
  • Price
  • ALT $4.19
  • ADV $1.54
  • Analyst Decision
  • ALT Strong Buy
  • ADV Strong Buy
  • Analyst Count
  • ALT 6
  • ADV 1
  • Target Price
  • ALT $18.20
  • ADV $2.50
  • AVG Volume (30 Days)
  • ALT 11.7M
  • ADV 712.4K
  • Earning Date
  • ALT 08-07-2025
  • ADV 08-06-2025
  • Dividend Yield
  • ALT N/A
  • ADV N/A
  • EPS Growth
  • ALT N/A
  • ADV N/A
  • EPS
  • ALT N/A
  • ADV N/A
  • Revenue
  • ALT $20,000.00
  • ADV $3,526,704,000.00
  • Revenue This Year
  • ALT N/A
  • ADV N/A
  • Revenue Next Year
  • ALT $1,557,547.90
  • ADV N/A
  • P/E Ratio
  • ALT N/A
  • ADV N/A
  • Revenue Growth
  • ALT N/A
  • ADV N/A
  • 52 Week Low
  • ALT $2.90
  • ADV $1.04
  • 52 Week High
  • ALT $11.16
  • ADV $4.16
  • Technical
  • Relative Strength Index (RSI)
  • ALT 39.67
  • ADV 54.54
  • Support Level
  • ALT $4.33
  • ADV $1.28
  • Resistance Level
  • ALT $4.79
  • ADV $1.67
  • Average True Range (ATR)
  • ALT 0.52
  • ADV 0.12
  • MACD
  • ALT -0.16
  • ADV 0.01
  • Stochastic Oscillator
  • ALT 26.92
  • ADV 66.67

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About ADV Advantage Solutions Inc.

Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.

Share on Social Networks: